Search

everythinglearnresearchcommunity

for

Search:↓

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Wnt/β-catenin signaling is important for keeping skin cell attachment structures stable.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Early over-expression of FoxN1 harms immune and skin development.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

A gene mutation in mice causes permanent hair loss and skin issues.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.